Characterization of AT1 and AT2 Receptor Expression Profiles in Human Skin During Fetal Life.

Hong-Wei Liu,Biao Cheng,Xiao-Bing Fu,Tong-Zhu Sun,Jian-Fu Li
DOI: https://doi.org/10.1016/j.jdermsci.2007.02.008
IF: 5.408
2007-01-01
Journal of Dermatological Science
Abstract:Angiotensin (Ang) II, a key peptide of renin-angiotensin system (RAS), plays a critical role in the regulation of cardiovascular homeostasis and exerts various actions on target organs. To date, at least two main Ang II receptor subtypes are defined: type 1 (AT1) and type 2 (AT2) receptors. The AT1 receptor mediates most of the known actions of Ang II, such as vasoconstriction, cellular growth, and accumulation of extracellular matrix [ [1] de Gasparo M. Catt K.J. Inagami T. Wright J.W. Unger T. International Union of Pharmacology. XX III. The angiotensin II receptors. Pharmacol Rev. 2000; 52: 415-472 PubMed Google Scholar ]. Although the exact functional role of AT2 receptor is still an enigma, it has been suggested that AT2 receptor activation lead to growth arrest [ [1] de Gasparo M. Catt K.J. Inagami T. Wright J.W. Unger T. International Union of Pharmacology. XX III. The angiotensin II receptors. Pharmacol Rev. 2000; 52: 415-472 PubMed Google Scholar ]. Recently, several lines of evidence has demonstrated the existence of a complete RAS in adult rodent and human skin [ 2 Yahata Y. Shirakata Y. Tokumaru S. Yang L. Dai X. Tohyama M. et al. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem. 2006; 281: 13209-13216 Crossref PubMed Scopus (113) Google Scholar , 3 Steckelings U.M. Wollschlager T. Peters J. Henz B.M. Hermes B. Artuc M. Human skin: source of and target organ for angiotensin II. Exp Dermatol. 2004; 13: 148-154 Crossref PubMed Scopus (120) Google Scholar ], that is upregulated under pathophysiological status such as skin injury and diffuse cutaneous systemic sclerosis [ 4 Abiko M. Rodgers K.E. Campeau J.D. Nakamura R.M. Dizerega G.S. Alterations of angiotensin II receptor levels in sutured wound in rat skin. J Invest Surg. 1996; 9: 447-453 Crossref PubMed Scopus (28) Google Scholar , 5 Kawaguchi Y. Takagi K. Hara M. Fukasawa C. Sugiura T. Nishimagi E. Harigai M. Kamatani N. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptor. Arth. Rheum. 2004; 50: 216-226 Crossref PubMed Scopus (95) Google Scholar ]. In addition, topical application of Ang II has been reported to accelerate cutaneous wound healing [ [6] Abiko M. Girgis W. St Amand K. Campeau J. Dizerega G. Acceleration of dermal tissue repair by angiotensin II. Wound Repair Regen. 1997; 5: 175-183 Crossref PubMed Scopus (45) Google Scholar ]. Despite the emergence of the potential importance of Ang II and its receptors in the dermatological field, little is known about the spatial and temporal change of Ang II receptor expression in developing skin, especially in humans. Thus, we examined the distribution and expression pattern of both AT1 and AT2 receptors in human fetal skin.
What problem does this paper attempt to address?